Latest News and Press Releases

The Board of Directors hereby convenes an Extraordinary General Meeting to be held at the Company’s address at Lyskjær 8A, 2730 Herlev on Thursday November 2nd 2023 at 10:00 AM (CEST). Agenda: ...

As described in Company Announcements 12/2023, the strategy for Orphazyme is to optimize the cost structure of the company, while the search for a new activity is ongoing. To reduce the running...

In accordance with the authorization from the General Meeting on May 17’th 2023 and Company announcement 8/2023 the Board of Directors in Orphazyme A/S has today introduced an incentive program for...

As communicated several times, latest in Company announcement 12/2023, Orphazyme is part of a US class action lawsuit. The court has granted preliminary approval of the proposed settlement and...

As mentioned in announcement 11/2023 the Company and CEO/CFO Anders Fink Vadsholt entered into a severance agreement at May 30th 2023, where Mr. Vadsholt would step down as CEO/CFO of the Company no...

Business updates and Financial highlights First Half 2023:Unless otherwise stated, comments in this announcement refer to H1 performance from continuing operations. In 2022, the business operations...

The board of directors and CEO/CFO Anders Fink Vadsholt has today entered into a severance agreement pursuant to which Mr. Vadsholt will step down as CEO/CFO of the Company. Regardless, Mr. Vadsholt...

Company announcement     No. 10/2023      Orphazyme A/S Ole Maaløes Vej 3DK-2200 Copenhagen N         www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, May 19, 2023 –...

Company announcement         Orphazyme A/SNo. 09/2023        Ole Maaløes Vej 3DK-2200 Copenhagen N www.orphazyme.comCompany Registration No. 32266355 Major shareholder announcement ...

Company announcement                                                                                        Orphazyme A/SNo. 8/2023 Ole Maaløes Vej 3DK-2200 Copenhagen N                               ...